Diode Laser 940 Nm Versus Electrosurgical Device During Second Stage Implant Surgery on Bone and Soft Tissue Healing

Hams Hamed Abdelrahman

Status: Completed

Conditions: Soft Tissue Healing; Dental Implant; Bone Healing

Treatments: Device: Electrosurgical; Device: Conventional surgery; Device: Diode laser 940 nm

Study type: Interventional

Funder types: Other

Identifiers

NCT06231134

0801-11/2023

Details and patient eligibility

About

Background: Dental lasers and electrosurgical devices have been introduced a long time ago. However, limited studies are available concerning their use in the second stage of implant surgery, with the conventional surgical technique being the standard of care.

Aim of this study: To evaluate clinically and radiographically soft and hard tissue healing associated with the use of electrosurgical and laser devices and compare them with conventional surgical techniques during second-stage implant surgery.

Plan of the study: A randomized controlled clinical trial. The sample size will include patients who have an implant already placed and ready for second stage surgery recruited from the patient pool at the outpatient clinics.

Materials and Methods: Patients will be randomly allocated into the three groups. In Group (A) implant will be exposed using the conventional surgical exposure techniques with a tissue punch, the cover screw will be removed, and the healing abutment placed. In group (B) implant will be uncovered using a diode laser (940nm) in contact type with a continuous mode at a power of 1.5 watts, the laser tip will be used in a circular motion to create a small opening which will be increased till large enough to expose and remove the cover screw and place the healing abutments. In group (C) the monopolar electrosurgical device will be used in the same way as the laser tip with additional care avoiding contacting the implants during exposure.

The outcome: will be soft tissue healing and crestal marginal bone loss around implants.

Soft tissue healing will be assessed on the operative day, 2 weeks, and 4 weeks using Landry index. Crestal bone loss will be assessed using a standardized periapical x-ray at baseline and after 1 month with periapical x-ray.

Enrollment: 33 patients

Sex: All

Ages: 25+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adequate zone of keratinized mucosa.
• Osseointegrated Implants ready for second-stage surgery.

Exclusion criteria

• Heavy smokers due to increased risk of infection, delayed wound healing, and poor immune response.
• Medically compromised patients due to affection of the peri-implant health and tissue maintenance.
• Bad oral hygiene
• Patients with an exposed cover screw
• Evidence of bone loss in the preoperative peri-apical radiograph.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

33 participants in 3 patient groups

Conventional surgery

Active Comparator group

Treatment:

Device: Conventional surgery

Dioad laser

Experimental group

Treatment:

Device: Diode laser 940 nm

Electrosuregry

Experimental group

Treatment:

Device: Electrosurgical